conference center.

Alemtuzumab Treatment Before Pregnancy and the Outcomes

Dr. Daniel Kantor 04/24/2017

Dr. Daniel Kantor speaks with Dr. Kerstin Hellwig from Bochum, Germany about a study on MS patients taking Alemtuzumab before pregnancy and the outcomes.

Leave a Reply

Your email address will not be published. Required fields are marked *

WE THANK ALLERGAN, BIOGEN, GENENTECH, MYLAN, NOVARTIS, SANOFI GENZYME & TEVA FOR SUPPORTING MSWORLD'S COVERAGE OF AAN 2017.

Information shared here is not for the diagnosis or treatment of any medical condition. For specific information and advice, consult your personal physician.
×
×

Leaving MSWorld.org

Words to explain why you're leaving

×